Results 171 to 180 of about 3,463,529 (362)
CHEMICAL TECHNOLOGY DIVISION UNIT OPERATIONS SECTION MONTHLY PROGRESS REPORT, JUNE 1958
J.C. Bresee +3 more
openalex +2 more sources
CHEMICAL TECHNOLOGY DIVISION, UNIT OPERATIONS SECTION MONTHLY PROGRESS REPORT, FEBRUARY 1962 [PDF]
M.E. Whatley +5 more
openalex +1 more source
THE LICENSING DILEMMA: UNDERSTANDING THE DETERMINANTS OF THE RATE OF LICENSING [PDF]
Licensing entails a tradeoff: licensing payments net of transaction costs (revenue effect) have to be balanced against the lower price-cost margin and/or reduced market share that the increased competition (profit dissipation effect) from the licensee ...
Andrea Fosfuri
core
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source
XII International scientific-technical conference «High chemical technologies-2008»
XII International scientific-technical conference is devoted to problems of: chemistry and technology of organic and inorganic materials, chemistry and technology medical products and biologically active substances, ecological and economic problems of ...
V. D. Yulovskaya, V. S. Timofeev
doaj
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez +5 more
wiley +1 more source
through Technology... Materials... Research... TRONA BORON CHEMICALS MAKE YOUR GOOD PRODUCTS BETTER [PDF]
openalex +1 more source
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima +6 more
wiley +1 more source
CHEMICAL PROCESSING TECHNOLOGY QUARTERLY PROGRESS REPORT, OCTOBER-DECEMBER 1961
J.R. ed. Bower
openalex +1 more source

